1. HYPERTENSION-
AN INTRODUCTION
PRESENTED BY
ASHUTOSH B. MAHALE
&DNYANESHWAR B. GAWADE
M.PHARMACY FIRST YEAR ( PHARMACOLOGY )
UNIVERSITY DEPARTMENT OF PHARMACEUTICAL SCIENCES, R.T.M NAGPUR UNIVERSITY ,
NAGPUR
2. INTRODUCTION
๏Defination-
๏Hypertension is a hemodynamic disorder
๏A well accepted definition of hypertension was suggested by Evans
and Rose: โ
๏Hypertension should be defined in the terms of blood pressure
level above which investigation and treatment do good more than
harmโ
๏ A patient is said to be hypertensive when his SBPโฅ 140 mm Hg &
DBP โฅ 90 mm Hg provided that the patient is not on
antihypertensive drugs.
3. REGULATION OF BLOOD PRESSURE
โข It means maintaining a constant blood pressure within a
narrow variation both increase in BP(hypertension) and
decrease in BP in (hypotension) are harmful in body.
โข The mechanism of regulation of BP is divided in to two
groups
โข Nervous regulation of BP.
โข Hormonal regulation of BP
Slow acting
mechanism
โข By change in GFR
Rapidaly acting
mechanism
5. Etiology of Hypertension
๏Primary (essential or idiopathic) hypertension
๏ Contributing factors
โข โ SNS activity
โข โ Sodium retaining hormones and vasoconstrictors
โข Diabetes mellitus
โข > Ideal body weight
โข โ Sodium intake
โข Excessive alcohol intake
6. SECONDARY
โข Elevated BP with a specific cause
5% to 10% of adult cases
๏ Contributing factors:
โข Renal disease
โข Endocrine disorders
โข Neurologic disorders
โข Cirrhosis
โข Sleep apnea
If someone under 20 or over 50 suddenly develops hypertension, esp.
severe then suspect secondary cause
HYPERTENSION
12. SYMPATHOLYTIC AGENTS
category Mechanism of action Side effect Drug interaction
Beta blocker (atenolol) cardiac output
Renin secretion
Intolerance,
Airways
obstruction
Accumulation of lidocaine
Alpha blocker (prazosin) Block noradrenaline
mediated tonic
vasoconstriction
Postural hypotension
Centrally acting adrenergic
agent (methyldopa)
Taken up by
noradrenergic
nerve terminals
and converted to
ฮฑ-methyl
noradrenaline,
which is released
as a false
transmitter. This
acts centrally
as an ฮฑ2-agonist
and reduces
sympathetic
outflow
Drowsiness, depression
13. CALCIUM CHANNEL BLOCKER
CATEGORY MECHANISM OF ACTION SIDE EFFCET DRUG INTERACTION
Dihydropyridine
(amlodipine )
Calcium-channel
blockers inhibit Ca2
influx through
voltage-
dependent L-type
calcium channels.
Cytoplasmic Ca2
concentrations control
the contractile state of
actomyosin.
Headache , flushing, ankle
swelling
Benzothiazepine
(diltiazem )
Generallly mild
Phenylaklylamine
(verapamil )
constipation i.V verapamil cause
circulatory collapse with
patient treated with alpha
blocker